http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 정서연(Seo-Yeon Chung) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
우리나라 프로톤펌프저해제 사용 양상에 대한 연구 : 2016-2020 보건의료빅데이터개방시스템 데이터를 이용한 분석
오주아(Joo-Ah Oh),이규민(Gyu-Min Lee),정서연(Seo-Yeon Chung),조유송(Yu-Song Cho),이혜재(Hye-Jae Lee) 대한약학회 2021 약학회지 Vol.65 No.4
Proton Pump Inhibitors (PPIs) are drugs that inhibit gastric acid secretion and are widely used globally. With the aging population and the rising prevalence of gastrointestinal diseases in Korea, the number of patients using PPIs is increasing. Therefore, we investigated the current state of PPI utilization at the national level using the nationwide database, Healthcare Bigdata Hub compiled by the Health Insurance Review and Assessment Service (HIRA). We extracted the statistics from 2016 to 2020 and re-organized them into monthly utilization by treatments. The cost and volume of use by region, provider type, and diagnostic code were extracted for five PPIs: pantoprazole, rabeprazole, omeprazole, esomeprazole, and lansoprazole. The volume of use was converted into Defined Daily Dose (DDD), which is the standardized unit of utilization. Esomeprazole and rabeprazole were the most commonly used PPIs, and esomeprazole has shown a sharp increase recently. The crude utilization of each region was the highest in Seoul, but that in Daegu and Jeonbuk was the highest after adjusting for the population size. The utilization of PPIs has increased in all diagnostic codes, and Gastroesophageal Reflux Disease (GERD) accounts for the highest proportion. Despite emerging concerns on the adverse outcomes of long-term PPI utilization, their consumption has increased in recent years. These results on the variations by region and trends by diagnostic code thus address a good basis for future research and policies regarding PPIs.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
